Core Data Elements
Number of Cases
1,255Case Sex
Female (648); Male (607)
Case Age At Diagnosis
0 to 4 years (1); 5 to 9 years (1); 10 to 14 years (10); 15 to 19 years (44); 20 to 24 years (154); 25 to 29 years (232); 30 to 34 years (354); 35 to 39 years (459)
Case Race
American Indian or Alaska Native (5); Asian (83); Black or African American (85); Native Hawaiian or Other Pacific Islander (2); White (997); Not Reported (54); Unknown (29)
Case Ethnicity
Hispanic or Latino (107); Not Hispanic or Latino (968); Not Reported (150); Unknown (30)
Case Disease Diagnosis
Acute monocytic leukemia (3); Acute myeloid leukemia with maturation (12); Acute myeloid leukemia without maturation (8); Acute myeloid leukemia, minimal differentiation (2); Acute myeloid leukemia, NOS (1); Acute myelomonocytic leukemia (5); Acute promyelocytic leukaemia, t(15;17)(q22;q11-12) (7); Adenocarcinoma with mixed subtypes (1); Adenocarcinoma, endocervical type (7); Adenocarcinoma, intestinal type (1); Adenocarcinoma, NOS (23); Adenoid cystic carcinoma (1); Adenoma, NOS (1); Adenosquamous carcinoma (1); Adrenal cortical carcinoma (31); Aggressive fibromatosis (2); Astrocytoma, anaplastic (53); Astrocytoma, NOS (42); Basal cell carcinoma, NOS (2); Basaloid squamous cell carcinoma (1); Cholangiocarcinoma (2); Chondrosarcoma, NOS (1); Choriocarcinoma combined with other germ cell elements (1); Choriocarcinoma, NOS (1); Clear cell adenocarcinoma, NOS (17); Clear cell carcinoma (1); Dedifferentiated liposarcoma (3); Diffuse large B-cell lymphoma, NOS (4); Embryonal carcinoma, NOS (28); Endometrioid adenocarcinoma, NOS (17); Endometrioid adenocarcinoma, secretory variant (1); Epithelioid mesothelioma, malignant (2); Extra-adrenal paraganglioma, malignant (1); Extra-adrenal paraganglioma, NOS (5); Fibromyxosarcoma (1); Germ cell tumor, NOS (1); Glioblastoma (67); Glomus tumor, NOS (1); Haemangioblastoma (2); Hepatocellular carcinoma, fibrolamellar (3); Hepatocellular carcinoma, NOS (29); Hodgkin lymphoma, NOS (2); Infiltrating duct and lobular carcinoma (2); Infiltrating duct carcinoma, NOS (69); Infiltrating duct mixed with other types of carcinoma (1); Invasive micropapillary carcinoma (1); Leiomyosarcoma, NOS (4); Liposarcoma, well differentiated (1); Lobular carcinoma, NOS (1); Malignant lymphoma, non-Hodgkin, NOS (1); Malignant melanoma, NOS (56); Malignant peripheral nerve sheath tumor (4); Mediastinal (thymic) large B-cell lymphoma (2); Medullary carcinoma, NOS (5); Mixed embryonal carcinoma and teratoma (1); Mixed epithelioid and spindle cell melanoma (2); Mixed germ cell tumor (40); Mixed glioma (71); Mucinous adenocarcinoma (3); Mucinous adenocarcinoma, endocervical type (5); Nodular melanoma (3); Nonencapsulated sclerosing carcinoma (2); Oligodendroglioma, anaplastic (20); Oligodendroglioma, NOS (51); Osteosarcoma, NOS (1); Papillary adenocarcinoma, NOS (152); Papillary carcinoma, columnar cell (6); Papillary carcinoma, follicular variant (35); Papillary transitional cell carcinoma (2); Paraganglioma, malignant (1); Paraganglioma, NOS (3); Pheochromocytoma, malignant (8); Pheochromocytoma, NOS (29); Renal cell carcinoma, chromophobe type (20); Secretory carcinoma of breast (1); Seminoma, NOS (112); Serous cystadenocarcinoma, NOS (15); Spindle cell melanoma, NOS (4); Squamous cell carcinoma in situ, NOS (2); Squamous cell carcinoma, keratinizing, NOS (13); Squamous cell carcinoma, large cell, nonkeratinizing, NOS (8); Squamous cell carcinoma, NOS (66); Superficial spreading melanoma (1); Synovial sarcoma, biphasic (2); Synovial sarcoma, NOS (2); Synovial sarcoma, spindle cell (3); Teratocarcinoma (3); Teratoma, benign (5); Teratoma, malignant, NOS (3); Thymoma, type AB, malignant (2); Thymoma, type B1, malignant (1); Thymoma, type B2, malignant (7); Tubular adenocarcinoma (1); Yolk sac tumor (2); Not Reported (6)
Case Tumor Site
Abdomen, NOS (1); Adrenal gland, NOS (39); Anterior mediastinum (6); Bladder, NOS (2); Body of stomach (1); Bone marrow (37); Brain, NOS (96); Breast, NOS (76); Cardia, NOS (1); Cecum (2); Cerebrum (199); Cervix uteri (84); Cheek mucosa (1); Choroid (4); Colon, NOS (3); Connective, subcutaneous and other soft tissues of head, face, and neck (2); Connective, subcutaneous and other soft tissues of lower limb and hip (8); Connective, subcutaneous and other soft tissues of thorax (3); Connective, subcutaneous and other soft tissues of trunk, NOS (2); Connective, subcutaneous and other soft tissues of upper limb and shoulder (1); Corpus uteri (2); Cortex of adrenal gland (31); Endocervix (1); Endometrium (16); Exocervix (1); Frontal lobe (1); Gastric antrum (2); Head of pancreas (1); Head, face or neck, NOS (4); Hepatic flexure of colon (1); Intrahepatic bile duct (2); Kidney, NOS (50); Larynx, NOS (2); Liver (32); Long bones of lower limb and associated joints (1); Lower limb, NOS (1); Lower third of esophagus (3); Lower-inner quadrant of breast (1); Lung, NOS (1); Lymph node, NOS (1); Lymph nodes of axilla or arm (1); Lymph nodes of head, face and neck (3); Lymph nodes of inguinal region or leg (1); Mandible (1); Nervous system, NOS (1); Occipital lobe (2); Other ill-defined sites (1); Ovary (16); Overlapping lesion of brain (1); Overlapping lesion of eye and adnexa (1); Overlapping lesion of lip, oral cavity and pharynx (2); Pituitary gland (1); Pleura, NOS (2); Rectosigmoid junction (4); Rectum, NOS (2); Retroperitoneum (10); Sigmoid colon (4); Skin, NOS (59); Specified parts of peritoneum (1); Temporal lobe (6); Testis, NOS (197); Thorax, NOS (1); Thymus (5); Thyroid gland (187); Tongue, NOS (11); Tonsil, NOS (3); Transverse colon (1); Upper limb, NOS (1); Upper lobe, lung (3); Vertebral column (1); Not Reported (2); Unknown (2)
Number of Samples
1,157Sample Assay Method
ATAC Sequencing (44); Diagnostic Slide (1,040); Genotyping Array (1,157); Methylation Array (1,133); miRNA Sequencing (1,096); Reverse Phase Protein Array (814); RNA Sequencing (1,101); Tissue Slide (1,119); Whole Exome Sequencing (1,101); Whole Genome Sequencing (1,079)